Trial intelligence / Profile preview

Effect of Sildenafil Citrate on Doppler Indices in IUGR

NCT02362399Completed

Sponsor
Al Hayat National Hospital
Start
Mar 2015
Primary completion
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of ASP-001 in intrauterine growth restriction (IUGR) (2 arms), sponsored by Al Hayat National Hospital. Primary endpoint: Improvement of the Doppler indices at 9 months. Started Mar 2015; status: completed.

02

Drugs

ASP-001
03

Conditions

intrauterine growth restriction (IUGR)

Beyond the preview

Go deeper on NCT02362399.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02362399.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call